Artificial Pancreas Devices System Market Report 2024 (Global Edition)

Global Artificial Pancreas Devices System Market Report 2024 Market Size Split by Device Type (Threshold Suspend Device Systems, Control-to-Range (CTR) Systems, Control-to-Target (CTT) Systems), by En...

Artificial Pancreas Devices System Market Report Description

We have various report editions of Artificial Pancreas Devices System Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Artificial Pancreas Devices System Market Insights Video

Competitive Landscape of the Artificial Pancreas Devices System Market

The competitive landscape of the Artificial Pancreas Devices System market is characterized by key players like Medtronic, Dexcom, and Tandem Diabetes Care, who lead with advanced technologies and comprehensive product offerings. Competition centers around innovation in glucose monitoring, insulin delivery, and system integration to enhance patient outcomes. Companies focus on developing closed-loop systems that automate insulin delivery based on real-time glucose levels. Additionally, ongoing R&D, strategic partnerships, and acquisitions are common strategies to stay competitive. Emerging players and startups also contribute by offering novel solutions and targeting niche markets, driving growth and technological advancement in the field.

April 2024: The release of the MiniMed 780G artificial pancreas system by Medtronic Plc, which boasts cutting-edge glucose sensor technology. The goal of this innovation is to improve diabetes management by improving accuracy and user experience. (Source https://www.bing.com/ck/a?!&&p=16c74fa38dc920e7JmltdHM9MTcyNDI4NDgwMCZpZ3VpZD0yNzhkNDcxYS02NDY1LTY2OWQtMmE2Yy01M2I0NjU2MzY3MDQmaW5zaWQ9NTQ4Mw&ptn=3&ver=2&hsh=3&fclid=278d471a-6465-669d-2a6c-53b465636704&psq=The+release+of+the+MiniMed+780G+artificial+pancreas+system+by+Medtronic+Plc%2c+which+boasts+cutting-edge+glucose+sensor+technology.+The+goal+of+this+innovation+is+to+improve+diabetes+management+by+improving+accuracy+and+user+experience.&u=a1aHR0cHM6Ly93d3cubWVkc2NhcGUuY29tL3ZpZXdhcnRpY2xlLzk5MTA5MSM6fjp0ZXh0PVRoZSUyMFVTJTIwRm9vZCUyMGFuZCUyMERydWclMjBBZG1pbmlzdHJhdGlvbiUyMGhhcyUyMGFwcHJvdmVkLHByZW9yZGVycyUyMGZvciUyMHRoZSUyMDc4MEclMjBvbiUyME1heSUyMDE1JTJDJTIwMjAyMy4&ntb=1 )

Top Companies Market Share in Artificial Pancreas Devices System Industry: (In no particular order of Rank)

• Medtronic Plc
• Bigfoot Biomedical
• Johnson & Johnson Services Inc.
• Tandem Diabetes Care
• Inc.
• Pancreum
• Inc.
• TypeZero Technologies
• LLC
• Beta Bionics
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Artificial Pancreas Devices System Market

Which Region Dominates the Artificial Pancreas Devices System Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue attributed to the high prevalence of diabetes, substantial investments in research and development, as well as sophisticated healthcare infrastructure. The U.S. and Canada are leading in technological advancements, regulatory approvals, and market adoption of artificial pancreas systems. North American companies are at the forefront of innovation, driving the development of sophisticated devices and integrated solutions. Additionally, strong support from healthcare policies and a well-established diabetes care ecosystem further contribute to the region's leading position in the global market.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Artificial Pancreas Devices System market because of rapid industrialization, urbanization, and increasing manufacturing activities in countries like China, India, and Southeast Asian nations. Rising environmental regulations and a focus on improving workplace safety further contribute to the demand for advanced dust collection solutions. Additionally, the region's growing investments in infrastructure development and technological advancements support robust market expansion, making it a key area of growth in various sectors.

The current report Scope analyzes Artificial Pancreas Devices System Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Artificial Pancreas Devices System Market

According to Cognitive Market Research, the global Artificial Pancreas Devices System market size was estimated at USD 251.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 100.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.2% from 2024 to 2031.

• According to Cognitive Market Research, the U.S. had a major share in the Artificial Pancreas Devices System market with a market size of USD 79.40 million in 2024 and is projected to grow at a CAGR of 17.0% during the forecast period. The nation's advancements in Advanced technology, strong R&D, and significant healthcare investment.
• The Canada Artificial Pancreas Devices System market had a market share of USD 12.08 million in 2024 and is projected to grow at a CAGR of 18.0% during the forecast period. Canada's strict due to advanced research, innovation, and supportive regulations.
• The Mexico Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 17.7% during the forecast period, with a market size of USD 9.16 million in 2024.

Europe Artificial Pancreas Devices System Market

According to Cognitive Market Research, the global Artificial Pancreas Devices System market size was estimated at USD 251.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 75.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.5% from 2024 to 2031.

• The United Kingdom Artificial Pancreas Devices System market had a market share of USD 12.68 million in 2024 and is projected to grow at a CAGR of 18.3% during the forecast period. In the U.K., Artificial Pancreas Devices System sales witness an upswing due to advanced technology, research, and strong healthcare infrastructure.
• The France Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 16.7% during the forecast period, with a market size of USD 6.94 million in 2024.
• According to Cognitive Market Research, the German Artificial Pancreas Devices System market size was valued at USD 14.95 million in 2024 and is projected to grow at a CAGR of 17.7% during the forecast period. In Germany, Artificial Pancreas Devices System surged due to advanced technology, strong R&D, and innovation.
• The Italy Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 16.9% during the forecast period, with a market size of USD 6.49 million in 2024.
• The Russia Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 16.5% during the forecast period, with a market size of USD 11.70 million in 2024.
• The Spain Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 16.6% during the forecast period with a market size of USD 6.19 million in 2024
• The Luxembourg Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 17.6% during the forecast period, with a market size of USD 2.34 million in 2024.
• The Portugal Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 17.3% during the forecast period, with a market size of USD 1.59 million in 2024.
• The Greece Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 17.8% during the forecast period, with a market size of USD 0.91 million in 2024.
• Rest of Europe's Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 16.2% during the forecast period, with a market size of USD 11.70 million in 2024.

Asia Pacific Artificial Pancreas Devices System Market

According to Cognitive Market Research, the global Artificial Pancreas Devices System market size was estimated at USD 251.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 57.87 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Artificial Pancreas Devices System market size was valued at USD 26.04 million in 2024 and is projected to grow at a CAGR of 20.5% during the forecast period. Artificial Pancreas Devices Systems surged in China due to advanced manufacturing, research investments, and market demand.
• The Japan Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 19.5% during the forecast period, with a market size of USD 7.99 million in 2024.
• The India Artificial Pancreas Devices System market had a market share of USD 6.94 million in 2024 and is projected to grow at a CAGR of 22.8% during the forecast period. India's leads due to cost-effective innovation and growing diabetes prevalence.
• The South Korean Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 20.1% during the forecast period, with a market size of USD 5.79 million in 2024.
• The Australian Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 20.7% during the forecast period, with a market size of USD 3.01 million in 2024.
• The South East Asia Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 22.0% during the forecast period, with a market size of USD 3.99 million in 2024.
• The Rest of Asia Pacific Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 20.8% during the forecast period, with a market size of USD 4.11 million in 2024.

South America Artificial Pancreas Devices System Market

According to Cognitive Market Research, the global Artificial Pancreas Devices System market size was estimated at USD 251.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 12.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Artificial Pancreas Devices System market size was valued at USD 5.38 million in 2024 and is projected to grow at a CAGR of 19.0% during the forecast period. Artificial Pancreas Devices Systems flourished in Brazil due to innovation and demand.
• Argentina's Artificial Pancreas Devices System market had a market share of USD 2.11 million in 2024 and is projected to grow at a CAGR of 19.3% during the forecast period. Argentina's technology is due to innovation and affordability.
• Colombia's Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 18.2% during the forecast period, with a market size of USD 1.12 million in 2024.
• Peru's Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 18.6% during the forecast period, with a market size of USD 1.03 million in 2024.
• Chile's Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 18.7% during the forecast period, with a market size of USD 0.91 million in 2024.
• The Rest of Latin America's Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 17.5% during the forecast period, with a market size of USD 2.03 million in 2024.

Middle East and Africa Artificial Pancreas Devices System Market

According to Cognitive Market Research, the global Artificial Pancreas Devices System market size was estimated at USD 251.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 5.03 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.7% from 2024 to 2031..

• The GCC Countries Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 19.5% during the forecast period, with a market size of USD 2.15 million in 2024. Artificial Pancreas Devices System sales flourish due to investment and innovation.
• The Egypt Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 19.0% during the forecast period, with a market size of USD 0.53 million in 2024.
• The South Africa Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 19.7% during the forecast period, with a market size of USD 0.80 million in 2024. Artificial Pancreas Devices System sales flourish in South Africa and excel in innovation, research, and local market adaptation.
• The Turkey Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 18.2% during the forecast period, with a market size of USD 0.43 million in 2024.
• The Nigeria Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 17.8% during the forecast period, with a market size of USD 0.53 million in 2024.
• The Rest of the MEA Artificial Pancreas Devices System market is projected to witness growth at a CAGR of 17.7% during the forecast period, with a market size of USD 0.59 million in 2024.

Artificial Pancreas Devices System Market Analysis

How are Segments Performing in the Global Artificial Pancreas Devices System Market?

Artificial Pancreas Devices System Market Device Type Segment Analysis

According to Cognitive Market Research, Threshold Suspend Device Systems stand out as the dominant category over the projected period due to their advanced technology that enhances glucose control and patient safety. These systems automatically suspend insulin delivery when glucose levels fall below a set threshold, preventing hypoglycemia. The integration of continuous glucose monitoring and insulin pump technologies offers more precise management of diabetes, leading to improved patient outcomes. This innovation addresses key challenges in diabetes care, such as preventing severe hypoglycemia and reducing the burden of constant glucose monitoring. As a result, Threshold Suspend Device Systems are increasingly preferred, driving significant market growth.

Control-to-range (CTR) Systems emerge as the fastest-growing category in the Artificial Pancreas Devices System market due to their precision in glucose regulation. By dynamically adjusting insulin delivery to maintain glucose levels within a target range, CTR systems enhance patient outcomes and safety. Their advanced algorithms enable real-time adjustments, reducing the risk of hypoglycemia and hyperglycemia. This high level of control appeals to both patients and healthcare providers, driving adoption. The continuous improvement in CTR technology and increasing demand for personalized diabetes management further fuel their rapid market growth, positioning CTR systems as a key driver in the evolution of APD technology.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Artificial Pancreas Devices System Industry. Request a Free Sample PDF!

Artificial Pancreas Devices System Market End-Use Segment Analysis

According to Cognitive Market Research, the dominant category is Hospitals due to their central role in advanced diabetes care and management. They are key adopters of cutting-edge technologies, including artificial pancreas systems, which offer real-time glucose monitoring and automated insulin delivery. Hospitals integrate these devices into comprehensive patient care plans, leveraging their resources for research, development, and clinical trials. Their infrastructure supports the deployment of sophisticated systems and provides essential feedback for product improvement. Additionally, hospitals' focus on improving patient outcomes and managing chronic diseases drives demand, facilitating the growth and adoption of artificial pancreas devices in clinical settings.

The fastest-growing category in the Artificial Pancreas Devices System market is Clinics due to their critical role in patient care and diabetes management. They provide real-world testing environments for these advanced devices, which integrate continuous glucose monitoring and insulin delivery to mimic natural pancreatic function. Clinics facilitate early adoption and evaluation, offering valuable feedback to improve device efficacy and user experience. They also support patient education and device training, driving increased adoption. As clinics adopt these systems and demonstrate their benefits, they accelerate market growth, influencing both patient outcomes and technological advancements in artificial pancreas systems.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion